Democrat Lawmaker Who Endorsed Trump Says He Has ‘Left the Plantation,’ Will Not Seek Reelection — Will Work to Reelect the President

Democrat Georgia State Rep. Vernon Jones has said that he will not be seeking reelection after he defied his party and endorsed President Donald Trump’s reelection.

Jones says that instead of running for reelection, he will be resigning and working to keep President Trump in office.

“Turn the lights off, I have left the plantation,” Jones said in a statement. “Someone else can occupy that suite. Therefore, I intend not to complete my term effective April 22, 2020.”

The Democrat lawmaker also tweeted about his decision, saying he will “do all I can” to reelect the president.

“Earlier today, I made the decision to not seek re-election to the Georgia House of Representatives,” he wrote. “I look forward, however, to continuing to serve my community in other ways and doing all I can to re-elect @realDonaldTrump. We will Make America Great Again.”

Though he is not seeking reelection, he still does not plan to leave the party.

“I don’t plan to leave the Democratic Party because somebody’s got to be in there to hold them accountable — hold them accountable to how they are treating black people [and] root out the bigotry,” he said on The Rashad Richey Morning Show on Wednesday after announcing his resignation.

Jones endorsed Trump last week, praising the president for the economy, criminal justice reform, and his support for historically black colleges.

Speaking to The Atlanta Journal-Constitution, Jones said that he thinks Trump is doing a good job on certain issues.

https://www.thegatewaypundit.com/2020/04/democrat-lawmaker-endorsed-trump-says-left-plantation-will-not-seek-reelection-will-work-reelect-president/

Official New York policy encouraged infectious COVID-19 patients to be sent back to nursing homes

Reminder: about half of COVID-19 deaths have been nursing home patients

https://twitter.com/ElonBachman/status/1252967501442531329

>>8886988

sauce

http://paltc.org/sites/default/files/AMDA-AHCA-NCAL%20Statement%20on%20State%20Advisories%20FINAL.pdf

https://twitter.com/MrsC_Assange/status/1252745790662905856

‘SIGNIFICANT RAMIFICATIONS’: Meat Shortage Fears Deepen As Tyson Foods Closes Its Largest Pork Plant Indefinitely

Tyson Fresh Meats, the beef and pork subsidiary of Tyson Foods, Inc. (NYSE: TSN), plans to indefinitely suspend operations at its Waterloo, Iowa, pork plant this week.

The facility, the company’s largest pork plant, has been running at reduced levels of production due to worker absenteeism, and will stop production mid-week until further notice. The facility’s 2,800 team members will be invited to come to the plant later this week for COVID-19 testing.

“Protecting our team members is our top priority and the reason we’ve implemented numerous safety measures during this challenging and unprecedented time,” said Steve Stouffer, group president of Tyson Fresh Meats. “Despite our continued efforts to keep our people safe while fulfilling our critical role of feeding American families, the combination of worker absenteeism, COVID-19 cases and community concerns has resulted in our decision to stop production.

“The closure has significant ramifications beyond our company, since the plant is part of a larger supply chain that includes hundreds of independent farmers, truckers, distributors and customers, including grocers,” Stouffer said. “It means the loss of a vital market outlet for farmers and further contributes to the disruption of the nation’s pork supply.”

Affected Waterloo team members will continue to be compensated while the plant is closed. The timing of resumption of operations will depend on a variety of factors, including the outcome of team member testing for COVID-19.

Tyson Foods has been focused on COVID-19 since January when it formed a company coronavirus task force. It has since implemented numerous measures to protect workers. It was one of the first food companies to start taking worker temperatures. The company started efforts to secure a supply of protective face coverings before the CDC recommended them and now requires their use in all facilities. In an effort to promote social distancing, plants like Waterloo have installed workstation dividers and are providing more breakroom space.

Tyson Foods’ other meat and poultry plants currently continue to operate, but some are running at reduced levels of production either due to the planned implementation of additional worker safety precautions or worker absenteeism.

https://breaking911.com/significant-ramifications-meat-shortage-fears-deepen-as-tyson-foods-closes-its-largest-pork-plant-indefinitely/

Seems like bacon is under attack

Private Equity Firm Wants Out Of Victoria’s Secret Deal

The deal to sell Victoria’s Secret to Sycamore Partners may not go ahead as planned if the private equity firm has its way.

Sycamore is reportedly looking to back out of the deal to purchase the lingerie retailer from parent company L Brands (LB) after it closed its stores, skipped rent payments, and furloughed employees because of the coronavirus pandemic, Reuters reported.

According to its court filing (via Reuters), Sycamore claims that “these actions were taken as a result of or in response to the COVID-19 pandemic is no defense to L Brands’ clear breaches of the transaction agreement.”

L Brands called the decision to halt the deal for Victoria’s Secret “invalid,” saying "L Brands will vigorously defend the lawsuit and pursue all legal remedies to enforce its contractual rights, including the right of specific performance.”

Sycamore Partners reached an agreement to acquire 55% ownership of Victoria’s Secret from L Brands in February. Victoria’s Secret is valued at $1.1. billion.

Shares of L Brands stock were down 24.30% as of 2:20 p.m. EDT on Wednesday.

https://www.ibtimes.com/private-equity-firm-wants-out-victorias-secret-deal-heres-why-2963268

Swiss Pharm Co Wins FDA Approval To Start Hydroxychloroquine Clinical Trials In U.S.

Swiss pharmaceutical company Novartis has won approval from the U.S. Food and Drug Administration to begin a clinical trial on the efficacy of hydroxychloroquine in treating hospitalized COVID-19 patients.

The trial will begin immediately in more than a dozen sites across the U.S. and will include about 440 patients.

“We recognize the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease,” John Tsai, head of global drug development and chief medical officer at the company, said in a statement.

The new approval to move forward with clinical tests follows an earlier authorization from the FDA to allow emergency use of the drug, more widely used as a treatment for malaria.

President Trump has repeatedly touted hydroxychloroquine as a possible “game-changer” in the battle against SARS-CoV-2, the virus that causes COVID-19.

“HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine,” Trump wrote on Twitter earlier this month. “The FDA has moved mountains – Thank You!”

https://www.thegatewaypundit.com/2020/04/swiss-pharm-co-wins-fda-approval-start-hydroxychloroquine-clinical-trials-u-s/